~~<i id='3D2EB2FB38'><strike id='3D2EB2FB38'><tt id='3D2EB2FB38'><pre id='3D2EB2FB38'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

hotspot

fashion

author：Wikipedia 2025-09-29 22:50:41 - browse：679

Roche’s announcement Monday that it would pay $310 million for rights to a hypertension treatment, zilebesiran, invented by the biotech firm Alnylam is evidence of a renewed interest on the part of large pharmaceutical companies for treatments for cardiovascular disease.

If things go well, Roche could pay Alnylam up to $2.8 billion in total.

Heart drugs were once the most lucrative category of pharmaceuticals, but they have been eclipsed by treatments for cancer and other diseases as drug firms have struggled to one-up existing treatments for high blood pressure and high cholesterol that are now available as cheap generics.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： FogPharma raises $145 million in rare Series E round

entertainment

focus

hotspot

entertainment

SebastienBozon/AFPviaGettyImagesLONDON—RocheonThursdaysaiditsrecentlyacquiredexperimentalobesitymedi

WSS

Ripples from Flovent's discontinuation is killing children with asthma

Adam's Biotech Scorecard: PDS Biotech's survival benefit is overstated

Obesity drug from Roche shows promise in early study

Scientists unlock the key to scar

Oak Street deal isn't the answer to health care's woes

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

hotspot

fashion

entertainment

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

CVS is willing to dump 10% of its Medicare Advantage members

Dobbs anniversary: the lost opportunity of abortion as health care

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

New air purifier tech could be key to improving indoor air quality

The United States must get value

In Memoriam: Notable people who died in 2023

Why getting cancer drugs just got harder for rural patients

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

STAT series 'Denied by AI' wins major journalism prizes

focus

Raw milk easy to obtain despite bird flu warning, FDA interstate ban

Readout Newsletter: Ironwood, Pfizer, FogPharma updates

WuXi Biologics beefs up its lobbying operation

How to fix the rural physician shortage in the U.S.

Kristina Burow of ARCH Venture Partners shares her next big bets STAT

STAT series 'Denied by AI' wins major journalism prizes

focus

focus

hotspot

entertainment